Lupin And DKSH To Market Five Alvotech Biosimilars In The Philippines

Reference Product Sales More Than $16bn In 2021

 
• By Rosalind Rei

Lupin’s Multicare Pharmaceuticals subsidiary in the Philippines will partner with distributor DKSH to market five Alvotech biosimilars. Alvotech’s biosimilars, which remain at the pre-approval stages, reference Prolia/Xgeva, Eylea, Simponi, and two more undisclosed molecules. 

Pile of pills, with one pill bearing the flag of the Philippines
The biosimilars named under the deal reference top-selling global drugs • Source: Shutterstock

More from Deals

More from Business